I re-read your original post as well as this new one, and

New Post Public Reply Private Reply Replies (2) Message Board
Drano sox0407 #44012
457
I re-read your original post as well as this new one, and you are conflating lowball bids with bids placed at the 52-week low. This is just not the case. I also do not believe that selling at the bid is greater than buying at the ask. That isn't what I see when I watch the bid/ask on my streamer. I definitely do NOT see selling pressure.

Several people have posted here repeatedly over the years that they are putting in lowball bids, and their definition is perhaps a nickel under the last trade. (They have posted what their bid is, or they have PM'ed me privately, and I can attest to this being the case.) This is a far cry from putting a bid at the 52-week low. A lowball bid and a bid at the yearly low are in no way the same thing.

I have looked at the Level 2 both at otcmarkets.com and at my broker's site, and there are often some sizable bids at prices from a penny or two to about a nickel below the last trade. These are most certainly lowball bids by any reasonable definition, and they are not at the 52-week low. I have noticed that my bids usually do not show up on Level 2, and others have told me the same thing. Thus, I think there is actually much more buying interest than what we individual traders are allowed to see.

My statement stands and is correct: when those sizable lowball bids are placed, they make it much more difficult for market makers to plunge the stock down and take people's stops out. (remember, I think it is FOOLISH to have stops in on a stock like this.)
When a stock has been attacked as IPIX has, it is good for stability of the stock price to have those lowball bids in, which make it hard for manipulators to take the stock down significantly on low volume and at low cost to the manipulators. If they are determined to take it down, they will have to fill many thousands of shares at prices that should be painful to them, because they will have to short stock to fill those lowball bids.

Those lowball bids are not hurting the stock; they give it stability. In fact, constantly buying at the ask gives the market makers an incentive to keep raising the ask, selling to the suckers at the high of day (by shorting), and then taking the stock down and covering at lower levels.

As far as buying at the ask and your supply/demand idea -- this might be true in a situation where the stock price had not been attacked by an avowed shortseller through articles, a frivolous lawsuit, and FUD posted on other websites. But, many long-time shareholders have witnessed much manipulation in the stock price. All you have to do is look at the closing trades yesterday and today -- the bids went in at the ask, and the trades crossed at a lower price than the ask. How is buying at the ask helping the stock price, when the market makers are determined to sell the stock at less than the ask?

Just as there is little real buying pressure right now, there is also little real selling going on. The long-time investors are not selling at these prices. And, many of them are fully invested already.

The volume we are seeing now is much, much less than the average from even two weeks ago. We've been seeing volume of around 100k shares or less, instead of the 270k shares that was the average for a long time.

I think we are now seeing what the "real" volume is, when there are not a bunch of churning trades. And we've also seen a pattern of the stock price being up for much or most of the day, and then a final trade that prevents it from closing at the price it traded at up until the very end.

The time to buy at the ask is when we have news, new eyeballs are on the stock, and new investors are buying. Until that time, those people who put the lowball bids in are doing current shareholders a great service -- by preventing the hedge fund manipulators from pounding the stock down on low volume.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 10

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 3

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 5

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 8

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 7

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 5

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 6

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 7

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 5

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 5

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading

Top 5 Most Recently Viewed Articles

Orano Faces Increased Challenges in Niger Amid Control Issues

Updated Category News Views 273

Orano's Current Situation in Niger In recent months, Orano has raised concerns regarding its operations in Niger, particularly with respect to the governance of SOMAÏR, where it holds the majority share. This situation has been complex, as the decisions made during board meetings are no longer being enacted, leading Orano to confirm that the Nigerien authorities have...

Continue Reading
Central New Energy Showcases Innovations at Global Event

Updated Category News Views 133

Central New Energy Takes Center Stage Recently, a significant event took place at the Istanbul Expo Center when the World Energy Congress & Exhibition unfolded. This prestigious gathering, known for being one of the longest-running new energy industry events, attracted over 300 exhibitors who showcased innovative technologies and solutions in the energy sector....

Continue Reading
Challenges for Short Sellers in the Energy Sector Ahead

Updated Category News Views 124

Challenges Faced by Short Sellers in the Energy Sector As the new year begins, short sellers in the energy sector have encountered difficulties, reflected in approximately $21.9 billion in year-to-date mark-to-market losses. This statistic highlights a decrease of 1.59%. Ihor Dusaniwsky, the Managing Director of Predictive Analytics at S3 Partners, noted that both the...

Continue Reading
Innovative Projects by NIIMBL to Transform Biopharmaceuticals

Updated Category News Views 248

NIIMBL Launches New Projects to Revolutionize Biopharmaceutical Manufacturing The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has recently unveiled 11 transformative projects aimed at addressing various challenges in the biopharmaceutical sector. These initiatives are part of Project Call 8.1, with an impressive total funding of...

Continue Reading
Salarius and Decoy Merge: Pioneering Next-Gen Therapeutics

Updated Category News Views 168

Exciting Merger Completion Between Salarius Pharmaceuticals and Decoy Therapeutics This merger marks a strategic alliance designed to propel the development of advanced peptide conjugate therapeutics through Decoy’s innovative IMP3ACT platform. Together, this unified company begins its journey with a solid pro forma cash position of $14 million, following the merger and...

Continue Reading